Pharmacology for Nurses · Antihypertensive and Antianginal Drugs
Angiotensin II Receptor Blockers (ARBs)
On this page 9 sections
In 30 seconds
Angiotensin II A hormone that constricts blood vessels and stimulates aldosterone release Full entry → receptor blockers (ARBs) are a drug class that lowers blood pressure by blocking the effects of angiotensin II, a powerful hormone that constricts blood vessels and drives salt and water retention. Their names share the suffix -sartan (e.g., losartan, valsartan, candesartan, irbesartan, telmisartan, olmesartan). ARBs work at the end of a cascade called the Renin–angiotensin–aldosterone system (RAAS) The hormone cascade (renin → angiotensin I → angiotensin II → aldosterone) that regulates blood pressure, sodium, and volume Full entry →: instead of stopping the production of angiotensin II (as ACE inhibitors do), they occupy the receptor where angiotensin II would normally bind, so the hormone cannot deliver its message to the tissue.
Because they act on the same system from a slightly different point, ARBs are often described as cousins of ACE inhibitors — similar benefits, a different mechanism, and a different side-effect signature (notably, far less coughing). They are used in the management of hypertension and heart failure, and they are commonly part of therapy for people with chronic kidney disease and diabetes because they reduce pressure inside the kidney's filtering units.
Why this matters
- Commonly prescribed: ARBs are among the most widely used antihypertensive drug classes worldwide, so nurses meet them on almost every unit — medical-surgical, cardiac, renal, and outpatient clinics.
- Silent disease, visible drug effects: Hypertension usually causes no symptoms, so the drug's effects (blood pressure readings, lab values, dizziness) are the main way therapy is judged. Nurses monitor those effects.
- Kidney protection: ARBs reduce protein in the urine and slow the decline of kidney function in many people with diabetic kidney disease — a major reason they matter beyond blood pressure numbers.
- Safety vigilance: ARBs can raise potassium, can harm a developing fetus, and can worsen kidney function in certain people (e.g., those with severe dehydration or bilateral renal artery stenosis). Knowing when to flag a lab value or report symptoms is core nursing responsibility.
- Exam relevance: Nursing and pharmacology licensing exams regularly compare ACE inhibitors and ARBs — mechanism, cough, potassium, pregnancy — so the contrast is high-yield.
The college version
Core Concepts
The RAAS: a short tour of the cascade
When blood pressure falls or the kidneys sense low sodium, the kidneys release renin, an enzyme that converts a liver protein (angiotensinogen) into angiotensin I. In the lungs, angiotensin-converting enzyme (ACE) clips angiotensin I into angiotensin II. Angiotensin II then acts through two main receptor types:
- AT1 receptors — the workhorses: they cause powerful vasoconstriction, stimulate the adrenal glands to release Aldosterone A hormone that makes the kidneys retain sodium/water and excrete potassium Full entry → (which makes the kidneys hold onto sodium and water and excrete potassium), and promote thirst and sodium retention. Most of angiotensin II's harmful effects in hypertension and heart failure run through AT1.
- AT2 receptors — generally opposite in character (vasodilation, tissue repair) and much less understood; blocking AT1 selectively leaves AT2 available.
How ARBs work
ARBs are selective AT1 receptor The cell-surface receptor that carries most of angiotensin II's harmful effects Full entry → antagonists. They bind to AT1 receptors and block angiotensin II from attaching, which produces:
- Vasodilation — blood vessels relax, so systemic vascular resistance and Afterload The resistance the heart must push against to eject blood Full entry → fall, lowering blood pressure.
- Reduced aldosterone release — less sodium and water retention, lower blood volume, and (in most people) a small rise in serum potassium.
- Reduced pressure inside the kidney's glomeruli — this is the basis of their renoprotective effect in chronic kidney disease, especially with Proteinuria Protein in the urine, a sign of kidney filter damage Full entry →.
- Reduced cardiac workload — less afterload and less volume mean the heart does less work, which helps in heart failure.
Because ARBs leave ACE intact, Bradykinin A peptide that dilates vessels and causes inflammation; normally broken down by ACE Full entry → (a peptide that ACE normally breaks down) is not allowed to accumulate. Bradykinin buildup is what causes the dry cough seen with ACE inhibitors — which is why ARBs are the usual alternative for people who cannot tolerate that cough. (The mechanism of the rare angioedema seen with both classes is still not fully understood and should be flagged for source/SME review.)
ARBs versus ACE inhibitors: the family contrast
| Feature | ACE inhibitors (-pril) | ARBs (-sartan) |
|---|---|---|
| Where they act | Block the enzyme ACE → less angiotensin II formed | Block the receptor AT1 → angiotensin II can't act |
| Bradykinin | Allowed to accumulate → cough common | Not affected → cough uncommon |
| Kidney/heart benefits | Yes (hypertension, heart failure, diabetic kidney disease) | Yes (same core indications) |
| Potassium | Can rise | Can rise |
| Pregnancy | Contraindicated — fetal harm | Contraindicated — fetal harm |
Both classes reduce aldosterone, so both can raise potassium, and both are contraindicated in pregnancy because they can injure the developing fetal kidneys and other organs.
Uses and monitoring themes
ARBs are used in the management of hypertension, heart failure (often when ACE inhibitors are not tolerated), and chronic kidney disease with proteinuria, and they are a first-line option for many people with diabetes and hypertension. Because hypertension is symptom-free, monitoring is lab- and measurement-driven:
- Blood pressure and heart rate trends tell the story of effect.
- Serum potassium can creep upward, especially in people with kidney impairment or those also taking potassium-sparing diuretics or supplements.
- Kidney function (creatinine, estimated GFR) may shift; a small rise early in therapy can be expected, but large or progressive rises need attention.
- Orthostatic blood pressure (lying-to-standing drop) helps catch hypotension, dizziness, and fall risk.
Nurses also assess adherence and barriers: ARBs are daily medications for a lifelong condition, and people may stop them when they "feel fine." Teaching should cover the purpose, what to report (dizziness, weakness, swelling, reduced urine output, irregular heartbeat), and the absolute need to avoid pregnancy while taking them.
Person-first, scope-aware care
Talk about "a person with hypertension" who "takes losartan," not "a hypertensive on an ARB." Blood pressure goals, monitoring schedules, and who may initiate or titrate therapy vary by guideline, state nurse practice act, and institutional policy — some settings use collaborative practice agreements where advanced practice nurses adjust therapy. Educational content describes the class; actual doses, schedules, and decisions must always be verified against current references, the facility formulary, and the prescriber's orders.
Common Confusions
| Do not confuse | With | Difference |
|---|---|---|
| ARBs (-sartan) | ACE inhibitors (-pril) | ARBs block the AT1 receptor; ACE inhibitors block the enzyme that makes angiotensin II. ARBs rarely cause cough; both raise potassium and are contraindicated in pregnancy |
| "Blocking angiotensin II" | "Destroying angiotensin II" | ARBs don't remove the hormone — they occupy its receptor so it can't act. Angiotensin II levels can even rise |
| Higher potassium | Lower potassium | Both ACE inhibitors and ARBs tend to raise potassium (less aldosterone) — unlike loop/thiazide diuretics, which tend to lower it |
| ARB kidney protection | ARBs cure kidney disease | They slow damage (less proteinuria, less intraglomerular pressure); they don't repair established damage |
| Hypotension with ARBs | Hypovolemia (low blood volume) | The drug can cause pressure to drop by vasodilation; volume loss from dehydration is a separate problem that makes ARB hypotension worse |
Eli explains
The same idea, in plain words
Explain it like I’m 10
Your body makes a hormone called angiotensin II that squeezes your blood vessels like someone squeezing a garden hose — that raises the pressure. ARB medicines put a little "do not disturb" sign on the door of the cells where that hormone tries to knock. The hormone still exists, but it can't get in, so the hose relaxes, the pressure comes down, and the kidneys stop holding onto extra salt and water. That's why these pills lower blood pressure and protect the kidneys.
Worked example
Mr. Chen, age 68, has hypertension and type 2 diabetes. He started an ACE inhibitor three months ago. His blood pressure is well controlled, but he has developed a persistent, dry, tickly cough that keeps him up at night. He tells the nurse, "I'd rather skip the pill than keep coughing like this."
The nurse recognizes the pattern: the cough is a well-known effect of ACE inhibitor therapy (bradykinin accumulation), not a cold. The nurse documents the cough, checks the current medication list, and reports the finding to the prescriber, who switches Mr. Chen to an ARB in the same therapeutic family. Two weeks later, Mr. Chen reports the cough is gone, his blood pressure remains controlled, and — because he was also told the ARB helps protect his kidneys from diabetic damage — he is taking the medication daily.
The teaching moment: the nurse explains that the new pill works on the same pressure-raising system but through a different door, which is why the cough usually does not follow. The nurse also reviews what to report — dizziness, weakness, swelling, or anything suggesting high potassium (though symptoms are often subtle, which is why labs matter) — and notes that potassium and kidney labs will be rechecked on the prescriber's schedule.
Safety note: This scenario describes a drug class and clinical reasoning only. Actual drug selection, doses, monitoring intervals, and lab thresholds vary by patient, guideline, and institution — always verify against current references, the formulary, and the prescriber's orders.
Key takeaways
- Suffix clue: ARBs end in -sartan (losartan, valsartan, candesartan, irbesartan, telmisartan, olmesartan); ACE inhibitors end in -pril.
- Mechanism: selective AT1 receptor blockade — angiotensin II is present but cannot act; this causes vasodilation, less aldosterone, less sodium/water retention, lower blood pressure.
- No cough (usually): because ARBs do not cause bradykinin accumulation, the dry ACE-inhibitor cough is largely avoided — the classic reason a person is switched from an ACE inhibitor to an ARB.
- Potassium watch: both ACE inhibitors and ARBs can raise serum potassium; monitor in people with kidney impairment and those taking potassium supplements or potassium-sparing diuretics.
- Pregnancy: ARBs are contraindicated in pregnancy (fetal kidney injury and other harm); confirm pregnancy status and teach contraception in people of childbearing potential.
- Kidney protection: ARBs reduce intraglomerular pressure and proteinuria — a pillar of therapy in diabetic kidney disease and chronic kidney disease.
- Dehydration risk: vomiting, diarrhea, or aggressive diuresis can combine with an ARB to cause hypotension and acute kidney injury; report dizziness, weakness, or reduced urine output.
- Dual blockade caution: combining an ACE inhibitor, ARB, and/or direct renin inhibitor is generally avoided or carefully monitored because of additive risks of hypotension, hyperkalemia, and kidney injury — decisions follow current evidence and prescriber orders.
Check yourself
6 review questions from the chapter. Try each one, then open the answer.
What receptor do ARBs block, and what are the two main consequences of that blockade?
Show answer
They block the AT1 receptor. Consequences: vasodilation (lower systemic vascular resistance, lower blood pressure, less afterload) and reduced aldosterone release (less sodium/water retention, lower volume, potassium can rise).
Why do ARBs cause less coughing than ACE inhibitors?
Show answer
ARBs leave ACE intact, so bradykinin is not allowed to accumulate — bradykinin buildup is what causes the dry ACE-inhibitor cough.
Name three monitoring points that matter for a person taking an ARB.
Show answer
Blood pressure and heart rate trends, serum potassium, and kidney function (creatinine/estimated GFR); orthostatic blood pressure and symptom reports (dizziness, weakness) also matter.
Why are ARBs considered kidney-protective in people with diabetic kidney disease?
Show answer
By reducing pressure inside the glomeruli (intraglomerular pressure) and lowering proteinuria, they slow the decline in kidney function seen with diabetic kidney disease.
Why must pregnancy be ruled out before starting an ARB?
Show answer
ARBs can injure the developing fetal kidneys and other organs; they are contraindicated in pregnancy, so pregnancy status and reliable contraception must be confirmed.
Your patient reports dizziness when standing. What assessment would you perform, and what would you report?
Show answer
Measure lying, sitting, and standing blood pressures and heart rate (orthostatic vital signs), ask about fluid intake and recent vomiting/diarrhea, check for other contributing medications, and report the findings and fall risk to the prescriber per institutional policy.
Study tools & related lessonsKey vocabulary · Related
Key vocabulary
- Angiotensin II
- A hormone that constricts blood vessels and stimulates aldosterone release
- AT1 receptor
- The cell-surface receptor that carries most of angiotensin II's harmful effects
- Renin–angiotensin–aldosterone system (RAAS)
- The hormone cascade (renin → angiotensin I → angiotensin II → aldosterone) that regulates blood pressure, sodium, and volume
- Aldosterone
- A hormone that makes the kidneys retain sodium/water and excrete potassium
- Bradykinin
- A peptide that dilates vessels and causes inflammation; normally broken down by ACE
- Proteinuria
- Protein in the urine, a sign of kidney filter damage
- Afterload
- The resistance the heart must push against to eject blood
- Orthostatic hypotension
- A blood pressure drop when moving from lying/sitting to standing
Sources & references
This lesson was adapted from the open educational references above; their licenses and attributions are preserved. See Copyright & Licensing.
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.